Andrew Petrosoniak discusses the complexities of using vasopressors in trauma resuscitation. Megan Landes talks about implementing HIV PEP and PrEP in emergency settings, tackling challenges and risk assessments. Justin Morgenstern and George Kovacs delve into the PREOXI trial, shedding light on innovative pre-oxygenation techniques. Brit Long focuses on blast crisis management in leukemia patients, while Leah Flanagan and Liam Loughrey address the rising concerns of nitrous oxide toxicity in recreational users. A blend of critical insights awaits!
Read more
AI Summary
Highlights
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
Understanding the importance of timely initiation of HIV PEP within 72 hours can significantly reduce transmission risks after exposure.
HIV transmission risk varies by exposure type, necessitating careful evaluation of source risks before administering PEP in emergency settings.
Pre-Exposure Prophylaxis (PrEP) offers ongoing protection for high-risk individuals, emphasizing the need for clinician awareness in patient counseling and support.
Deep dives
Understanding HIV Post-Exposure Prophylaxis (PEP)
Post-Exposure Prophylaxis (PEP) is an effective method to reduce the risk of HIV transmission after potential exposure. It must be initiated within 72 hours of exposure and typically consists of a 28-day course of antiretroviral therapy (ART), which can decrease the likelihood of infection by up to 80%. The risk from a single exposure can be quantified; for instance, percutaneous exposure to HIV-positive blood has a transmission risk reduced to 0.3%, while mucocutaneous exposure is lowered to 0.09%. Understanding PEP's significance and prompt administration is crucial for emergency department practitioners.
Assessing Source Risk for HIV Transmission
Evaluating the source of potential HIV exposure is critical in determining PEP necessity. There are three categories of source risk: substantial, low but non-zero, and negligible. A source is deemed substantial if it is an HIV-positive individual with a high viral load or from a high-prevalence population, like individuals who inject drugs. Conversely, a negligible source might include an undetectable HIV-positive status with no STIs, indicating that not every HIV-positive patient poses equal risk.
Determining Risk by Type of Exposure
The likelihood of HIV transmission varies by the type of exposure, which should be considered before administering PEP. For instance, anal receptive intercourse has the highest per-act transmission risk at 1.38%, while needle sharing carries a risk of 0.63%. It is essential to weigh this risk against the nature of the exposure, as lower risk activities determine whether PEP is warranted. Clinicians must be prepared to inform patients about the risks based on their specific encounters and make evidence-based recommendations.
Pre-Exposure Prophylaxis (PrEP) Overview
Pre-Exposure Prophylaxis (PrEP) is designed for individuals at ongoing risk of HIV exposure, offering protection through regular antiretroviral therapy. This approach demonstrates a 44% reduction in HIV acquisition, highlighting its relevance in high-risk populations, such as sexually active individuals without consistent condom use. PrEP should not be confused with PEP; rather, it is part of a comprehensive prevention strategy for at-risk patients. Clinicians should be ready to counsel suitable patients on the benefits and protocols surrounding PrEP.
Navigating Costs and Side Effects of Antiretroviral Treatments
While antiretroviral medications have become more tolerable and generally effective, they can still have significant side effects and cost implications. Common adverse effects may include gastrointestinal issues, and the expense of these medications is a critical concern, particularly for patients with limited financial resources. Many emergency departments have protocols to provide initial 3-day doses of PEP to facilitate timely access while longer-term solutions are arranged. Involving social services and infectious disease specialists can assist with follow-up and medication access resources for patients facing financial barriers.
In this month's EM Quick Hits podcast: Andrew Petrosoniak on the role of vasopressors in the hemorrhaging trauma patient, Megan Landes on providing HIV PEP and PrEP in the ED, Justin Morgenstern & George Kovacs on the PREOXI trial and evidence for pre-oxygenation with NIPPV before intubation in RSI, Brit Long on recognition and management of blast crisis in the ED, and Leah Flanagan & Liam Loughrey on the rise of nitrous oxide toxicity...
Help Support EM Cases by Giving a Donation here: https://emergencymedicinecases.com/donation/
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode